Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results

Go back to Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
(NASDAQ: MRSN) Delayed: 29.08 --0 (-0%)
Previous Close $29.08    52 Week High
Open $29.08    52 Week Low
Day High $29.08    P/E N/A 
Day Low $29.08    EPS
Volume 37,400